CERT

Certara, Inc. (NASDAQ:CERT) is a biosimulation software and services company founded in 2008 and headquartered in Princeton, New Jersey. The company went public in December 2020 and has grown through strategic acquisitions to become a leading provider of model-informed drug development solutions. Certara serves over 2,400 life sciences companies, academic institutions, and government organizations across 19 countries, helping pharmaceutical and biotechnology companies accelerate drug discovery and development through advanced computational modeling and simulation technologies.